Real-world increase in biomarker testing in lung cancer patients, registry study reveals
More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry ...
Mar 23, 2022
0
1